DK1301207T3 - Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin - Google Patents
Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillinInfo
- Publication number
- DK1301207T3 DK1301207T3 DK01952176T DK01952176T DK1301207T3 DK 1301207 T3 DK1301207 T3 DK 1301207T3 DK 01952176 T DK01952176 T DK 01952176T DK 01952176 T DK01952176 T DK 01952176T DK 1301207 T3 DK1301207 T3 DK 1301207T3
- Authority
- DK
- Denmark
- Prior art keywords
- sulbactam
- ampicillin
- compositions
- treatment
- bacterial infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21541800P | 2000-06-30 | 2000-06-30 | |
| US23277300P | 2000-09-15 | 2000-09-15 | |
| US27930601P | 2001-03-28 | 2001-03-28 | |
| PCT/US2001/019712 WO2002002095A2 (en) | 2000-06-30 | 2001-06-21 | Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1301207T3 true DK1301207T3 (da) | 2005-10-10 |
Family
ID=27396119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01952176T DK1301207T3 (da) | 2000-06-30 | 2001-06-21 | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6544991B2 (da) |
| EP (1) | EP1301207B1 (da) |
| JP (1) | JP2004501965A (da) |
| AR (1) | AR029544A1 (da) |
| AT (1) | ATE301474T1 (da) |
| AU (1) | AU2001272961A1 (da) |
| DE (1) | DE60112581T2 (da) |
| DK (1) | DK1301207T3 (da) |
| ES (1) | ES2245698T3 (da) |
| MY (1) | MY128739A (da) |
| PE (1) | PE20020295A1 (da) |
| PT (1) | PT1301207E (da) |
| TW (1) | TWI265030B (da) |
| WO (1) | WO2002002095A2 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003030906A1 (en) * | 2001-10-11 | 2003-04-17 | Pharmacia & Upjohn Company | Treating infections by administration of oxazolidinones to the skin |
| JP2005527575A (ja) * | 2002-03-29 | 2005-09-15 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 糖尿病性足病変感染を治療するためのオキサゾリジノンの非経口、静脈内および経口投与 |
| AU2003224345A1 (en) * | 2002-04-30 | 2003-11-17 | Orchid Chemicals & Pharmaceuticals | Antibacterial agents |
| CA2607143A1 (en) * | 2005-05-06 | 2006-11-16 | Wyeth | Delivery of tigecycline in the presence of heparin |
| DK1899331T3 (da) | 2005-06-29 | 2010-03-08 | Pharmacia & Upjohn Co Llc | Homomorpholinoxazolidnoner som antibakterielle midler |
| WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
| WO2007086012A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation of cefpodoxime, clavulanic acid and linezolid |
| WO2007086014A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefpirome, tazobactam and linezolid |
| WO2007086013A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising of ceftazidime, tazobactam and linezolid |
| WO2008090570A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Novel antimicrobials |
| JP5662940B2 (ja) | 2008-11-20 | 2015-02-04 | パナセア バイオテック リミテッド | 新規な抗微生物薬 |
| BR112012000657A2 (pt) | 2009-06-26 | 2016-11-16 | Panacea Biotec Ltd | novos azabicilohexanos |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985648A (en) | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
| GB902703A (en) | 1960-08-25 | 1962-08-09 | Beecham Res Lab | Penicillins |
| BE641785A (da) | 1962-12-26 | |||
| US4234579A (en) | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| EP0856002B1 (en) | 1995-09-01 | 2001-10-24 | PHARMACIA & UPJOHN COMPANY | Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
| DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| EP1114819B1 (en) | 1996-04-11 | 2008-01-09 | Pharmacia & Upjohn Company LLC | Process to prepare oxazolidinones |
| CA2634657A1 (en) | 1997-11-07 | 1999-05-20 | Pharmacia & Upjohn Company | Process to produce oxazolidinones |
| DE60001807T2 (de) | 1999-02-01 | 2003-11-06 | Upjohn Co | VERFAHREN ZU HERSTELLUNG VON o-FLUORIERTEN TETRAHYDROTHIOPYRAN CARBAMATEN |
-
2001
- 2001-06-21 ES ES01952176T patent/ES2245698T3/es not_active Expired - Lifetime
- 2001-06-21 EP EP01952176A patent/EP1301207B1/en not_active Expired - Lifetime
- 2001-06-21 WO PCT/US2001/019712 patent/WO2002002095A2/en active IP Right Grant
- 2001-06-21 DE DE60112581T patent/DE60112581T2/de not_active Expired - Fee Related
- 2001-06-21 JP JP2002506717A patent/JP2004501965A/ja active Pending
- 2001-06-21 AU AU2001272961A patent/AU2001272961A1/en not_active Abandoned
- 2001-06-21 AT AT01952176T patent/ATE301474T1/de not_active IP Right Cessation
- 2001-06-21 US US09/886,641 patent/US6544991B2/en not_active Expired - Fee Related
- 2001-06-21 DK DK01952176T patent/DK1301207T3/da active
- 2001-06-21 PT PT01952176T patent/PT1301207E/pt unknown
- 2001-06-28 PE PE2001000643A patent/PE20020295A1/es not_active Application Discontinuation
- 2001-06-29 TW TW090115958A patent/TWI265030B/zh not_active IP Right Cessation
- 2001-06-29 MY MYPI20013131A patent/MY128739A/en unknown
- 2001-06-29 AR ARP010103125A patent/AR029544A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002095A3 (en) | 2003-02-06 |
| DE60112581D1 (de) | 2005-09-15 |
| ES2245698T3 (es) | 2006-01-16 |
| DE60112581T2 (de) | 2006-06-01 |
| AU2001272961A1 (en) | 2002-01-14 |
| WO2002002095B1 (en) | 2004-03-25 |
| US6544991B2 (en) | 2003-04-08 |
| JP2004501965A (ja) | 2004-01-22 |
| MY128739A (en) | 2007-02-28 |
| AR029544A1 (es) | 2003-07-02 |
| US20020022610A1 (en) | 2002-02-21 |
| ATE301474T1 (de) | 2005-08-15 |
| PE20020295A1 (es) | 2002-04-07 |
| EP1301207A2 (en) | 2003-04-16 |
| PT1301207E (pt) | 2005-11-30 |
| TWI265030B (en) | 2006-11-01 |
| EP1301207B1 (en) | 2005-08-10 |
| WO2002002095A2 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1065789A1 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents. | |
| GB0125222D0 (en) | Composition for the treatment of microbial infections | |
| DK1448234T3 (da) | Formuleringer, der omfatter en cephalosporinforbindelse, og deres anvendelse til behandling af bakterieinfektioner hos katte og hunde | |
| ATE397929T1 (de) | Glukokinase beeinflussende verbindungen | |
| DK2128246T3 (da) | Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar. | |
| DK1562968T3 (da) | Anti-il-6-antistoffer, sammensætninger, fremgangsmåder og anvendelser | |
| IS6448A (is) | Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni | |
| WO2003088897A3 (en) | Fab i inhibitors | |
| DE60109207T8 (de) | Orale zusammensetzung | |
| IL168747A0 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents | |
| NO20025204D0 (no) | Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner | |
| DK1301207T3 (da) | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin | |
| ZA200101821B (en) | Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection. | |
| DK1183269T3 (da) | Svækkede mikroorganismer til behandlingen af infektion | |
| NO20014314L (no) | Blandinger og metoder for behandling av stafylokokkisk infeksjon | |
| DK1380121T3 (da) | Fremgangsmåde til fremstilling af oxazolidinoner | |
| AU2002232558A1 (en) | Compounds, compositions and methods for treatment of parasitic infections | |
| DK1656143T3 (da) | Quinolon-antibiotika til behandling af periodontale infektioner | |
| DE60228478D1 (de) | Aryl-annellierte azapolyzyklische verbindungen | |
| DK1459748T3 (da) | (S,S)-reboxetin til behandling af perifer neuropati | |
| SI1301207T1 (sl) | Sestavki za zdravljenje bakterijskih infekcij, ki vsebujejo oksazolidinonsko spojino, sulbaktam in ampicilin | |
| DK1105101T3 (da) | Fremgangsmåder og præparater til behandling af intracellulære infektioner | |
| DK1411908T3 (da) | Nitrogenoxidgenererende sammensætning til behandling af subunguale infektioner | |
| ES1049329Y (es) | Ladrillo perfeccionado. | |
| AU2002348440A1 (en) | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |